Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 78

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4
Chunk 78
---
 will be selected to advance to Phase III. For genome editing and advanced breeding products, the end of this    
                                                   phase will lead straight to Phase IV (Pre-Launch).                                              
---------------------------------------------------------------------------------------------------------------------------------------------------

◾                                           Phase III, or “Advanced Development and Regulation”: This                                        
    phase is relevant only for the development of GM products. Extensive field trials are performed to test the effectiveness of the selected
    product candidate across locations, and regulatory approvals are obtained, including potential environmental impact assessments, toxicity
                              and allergenicity. We estimate the duration of Phase III is between one to two years.                          
---------------------------------------------------------------------------------------------------------------------------------------------

◾                                           Phase IV, or “Pre-Launch”: This phase involves preparation                                        
    for commercial launch. The range of activities here includes preparing the seeds for commercial sales, formulation of a marketing strategy
                    and preparation of marketing materials. We estimate the duration of Phase IV is between one to two years.                 
----------------------------------------------------------------------------------------------------------------------------------------------
 
As indicated, the estimated timeframes of phase duration are based on our experience and estimates according to available information. The total development time for a particular product may be longer or shorter than the duration presented above depending on a range of factors.
 
Product Development Pipeline
 
The following table sets forth our key product development programs in the segment of yield and abiotic stress tolerance seed traits under development with our collaborators:

Program           Crop          Technology             Collaborator             Development Phase
-------------------------------------------------------------------------------------------------
1         Canola and rapeseed   GM           As part of Crop4Clima consortium   Phase I          
 
The following table sets forth our key product development programs in the segment of disease resistance traits, under development with our collaborators:
 

Program     Crop      Trait       Technology     Collaborator   Development Phase
---------------------------------------------------------------------------------
1         Soybean   Nematodes   Genome editing   TMG            Discovery        
 

The following table sets forth our key product development programs in the segment of food security, under development with our collaborators:
 

Program    Food Element    Crop    Technology    Collaborator   Development Phase
---------------------------------------------------------------------------------
1         Bovine Casein   Potato   GMO          Finally Foods   Phase 1          
Key Collaborations
 
TMG
 
In December 2018, we entered into a multi-year collaboration and license agreement with TMG, a major Brazilian developer and marketer of soybean varieties, for the development of nematode-resistant soybean varieties using genome editing technologies. Under the agreement, we identified genomic elements for editing to attribute nematode resistance in soybean and perform such edits on TMG’s commercial